Doan N. Singh
FDA investigator
Appears on 2 documents from 2010 to 2023, mostly at sites in California. Most often cites design and construction features (21 CFR 211.42).
- 2
- Documents on file
- 11.5
- Observations per 483
- 2010
- First seen
- 2023
- Most recent
What they cite most
From 23 observations- 21 CFR 211.42Design and construction features4
- 21 CFR 211.100Written procedures; deviations3
- 21 CFR 211.160General requirements3
- 21 CFR 211.113Control of microbiological contamination2
- 21 CFR 211.165(a)Testing and release for distribution2
- 21 CFR 211.22Responsibilities of quality control unit2
Activity by year
2010: 1, 2023: 1
Where
California 1 · Kansas 1
Often inspects with
Is Doan N. Singh coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2023-08-25 | 483 Central Admixture Pharmacy Services IncAug 25, 2023 · San Diego, California | San Diego, California | 17 | |
| 2010-02-03 | 483 Hospira, Inc.Feb 3, 2010 · McPherson, Kansas | McPherson, Kansas | 6 |
About this profile
What does Doan N. Singh inspect?
Doan N. Singh appears on 2 documents on file covering 2 sites, mostly in California.
What do they cite most often?
21 CFR 211.42 (design and construction features), followed by 21 CFR 211.100 and 21 CFR 211.160.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Doan N. Singh is dated Aug 25, 2023.